The effect of dapagliflozin ointment on induced psoriasis in an experimental model
Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treat...
Saved in:
Published in | Journal of medicine and life Vol. 17; no. 3; pp. 281 - 285 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Romania
Carol Daila University Foundation
01.03.2024
Carol Davila University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment. |
---|---|
AbstractList | Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment. Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment.Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules. The primary objective of this research was to develop a topical ointment formulation containing dapagliflozin and assess its efficacy in treating psoriasis using an imiquimod-induced psoriasis model. A total of 16 Swiss albino mice, with weights ranging from 24 to 30 grams, were allocated randomly into six groups, each group including ten animals. The study assessed the effects of various concentrations of dapagliflozin ointment on levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-8 (IL-8), IL-17, and IL-37, as well as on erythema, scaling, and epidermal thickness. Dapagliflozin ointment significantly reduced these cytokine levels and disease scores, indicating anti-psoriatic and anti-inflammatory properties. Therefore, when applied topically, dapagliflozin ointment had strong efficacy against imiquimod-induced psoriatic skin inflammation, suggesting its potential as a novel therapeutic option for psoriasis treatment. |
Author | Bdioui, Ahlem Al-Gazally, Moaed Al-Saedi, Haider Ramadhan, Mukhallad Salah, Sihem Hmissa Belhaj Al Bahadly, Waleed Khaled Younis |
Author_xml | – sequence: 1 givenname: Waleed Khaled Younis surname: Al Bahadly fullname: Al Bahadly, Waleed Khaled Younis organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia – sequence: 2 givenname: Ahlem surname: Bdioui fullname: Bdioui, Ahlem organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia – sequence: 3 givenname: Moaed surname: Al-Gazally fullname: Al-Gazally, Moaed organization: Department of Clinical Biochemistry, College of Medicine, University of Al-Ameed, Karbala, Iraq – sequence: 4 givenname: Haider surname: Al-Saedi fullname: Al-Saedi, Haider organization: Department of Pharmacology, College of Pharmacy, University of Al-Ameed, Karbala, Iraq – sequence: 5 givenname: Sihem Hmissa Belhaj surname: Salah fullname: Salah, Sihem Hmissa Belhaj organization: Department of Physiology, Faculty of Medicine Ibn Al Jazzar, University of Sousse, Sousse, Tunisia – sequence: 6 givenname: Mukhallad surname: Ramadhan fullname: Ramadhan, Mukhallad organization: Department of Pathology, College of Medicine, University of Misan, Misan, Iraq |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39044933$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkM1LAzEQxYNUbK1ePUrAi5fVfO52TyLiFwiCKHhb0mRiU7LJuumK-tcbsYo6lxlmHo_fvG00CjEAQnuUHDFJGTtetr5ghPGCkJnYQBM6E6LglFaj9ZxFj2O0m9KS5BKyLEu-hca8JkLUnE_Q3f0CMFgLeoWjxUZ16sk76-O7Czi6sGoh5EvALphBg8Fdir1TyaW8wSpgeO2gd58q5XEbDfgdtGmVT7C77lP0cHF-f3ZV3NxeXp-d3hQdFYQVlApeGyAMhLUzPS-1KLm0umSEWpVJLTGV4nU117Sq5zXIijEuDUjDBaeaT9HJl283zFswOiP0yjddplH9WxOVa_5egls0T_GloZSVrMyxTdHh2qGPzwOkVdO6pMF7FSAOqeE5VcJqmkObooN_0mUc-pD_azglUlLJqk_D_d9IPyzfefMPNUyE3A |
ContentType | Journal Article |
Copyright | 2024 by the authors. Copyright Carol Daila University Foundation Mar 2024 2024 by the authors. 2024 |
Copyright_xml | – notice: 2024 by the authors. – notice: Copyright Carol Daila University Foundation Mar 2024 – notice: 2024 by the authors. 2024 |
DBID | CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI BYOGL CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.25122/jml-2023-0084 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection East Europe, Central Europe Database ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition East Europe, Central Europe Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BYOGL name: East Europe, Central Europe Database url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/eastcentraleurope sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1844-3117 |
EndPage | 285 |
ExternalDocumentID | 39044933 |
Genre | Journal Article |
GroupedDBID | --- 3V. 53G 7X7 88E 8FE 8FH 8FI 8FJ 8R4 8R5 ABDBF ABUWG ACPRK ADBBV AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI BYOGL CCPQU CGR CUY CVF DIK EBD ECM EIF EMOBN EOJEC ESX F5P FYUFA HCIFZ HMCUK HYE KQ8 LK8 M1P M7P MK0 NPM O5R O5S OBODZ OK1 PGMZT PQQKQ PROAC PSQYO Q2X RPM SV3 TR2 TUS UKHRP 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-p1402-11439de02e4ff8cb6c4635fc6201fa566f0d7a397bc179b9e572235de5d3431c3 |
IEDL.DBID | RPM |
ISSN | 1844-122X 1844-3117 |
IngestDate | Tue Sep 17 21:27:53 EDT 2024 Sat Oct 26 04:34:19 EDT 2024 Thu Oct 10 20:47:45 EDT 2024 Sat Nov 02 12:21:45 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Keywords | mice dapagliflozin psoriasis imiquimod |
Language | English |
License | 2024 by the authors. This open access article is published and licensed by the Journal of Medicine and Life under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-p1402-11439de02e4ff8cb6c4635fc6201fa566f0d7a397bc179b9e572235de5d3431c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11262602/ |
PMID | 39044933 |
PQID | 3105515272 |
PQPubID | 136187 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11262602 proquest_miscellaneous_3084029166 proquest_journals_3105515272 pubmed_primary_39044933 |
PublicationCentury | 2000 |
PublicationDate | 2024-Mar 20240301 |
PublicationDateYYYYMMDD | 2024-03-01 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-Mar |
PublicationDecade | 2020 |
PublicationPlace | Romania |
PublicationPlace_xml | – name: Romania – name: Bucharest |
PublicationTitle | Journal of medicine and life |
PublicationTitleAlternate | J Med Life |
PublicationYear | 2024 |
Publisher | Carol Daila University Foundation Carol Davila University Press |
Publisher_xml | – name: Carol Daila University Foundation – name: Carol Davila University Press |
SSID | ssj0000456663 |
Score | 2.3386645 |
Snippet | Dapagliflozin is a pharmacological drug commonly used to manage type 2 diabetes by inhibiting the sodium-glucose cotransporter in the proximal renal tubules.... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 281 |
SubjectTerms | Albinism Animals Benzhydryl Compounds - pharmacology Biomarkers Cytokines Cytokines - metabolism Diabetes Disease Models, Animal Erythema Glucose Glucosides - administration & dosage Glucosides - pharmacology Glucosides - therapeutic use Imiquimod Inflammation Keratin Male Mice Ointments Original Psoriasis Psoriasis - chemically induced Psoriasis - drug therapy Psoriasis - pathology Tumor necrosis factor-TNF Variance analysis |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFA46QbyIv61OieA1LCZtup5ExCHCPIiD3kbSJFqZabXbxb_el7abm4LXNpT2vTTvey8v34fQpc5sYpWmhOpY-9JNSCTjihiI1RJirFLaHxQePor7UfiQRmlbcKvatsr5mlgv1LrIfI28x72So9dgZdflB_GqUX53tZXQWEcbV4wK39IVp_GixuLhiqjF1CCP8fR8LG14G31QZ7239wnx6uGE1uSmfxHm70bJpcgz2EHbLWTEN42Pd9GacXtoc9huiu-jJ3A1bvoycGGxhvD3MsntpPjKHS5yV_eR48JhSL_BkRqXFXyYrPIKrmDp8DLLP66lcQ7QaHD3fHtPWqkEUkKGxAhkNTzRhjITWtvPlMhCQBI2ExDfrQQrWPCFBOyhMvgDVWKiGHBBpE2kOUCIjB-ijiucOUY45kLLiBkBjwkTRSWVpg8DhYJlnSsToO7cUON2vlfjH-8E6GJxG2aq336QzhQzGANWpgzgqAjQUWPXcdlQaox5QsMw4TxA_RWLLwZ4FuzVOy5_rdmw_RkoSMrYyf_vdYq2wNdh0z7WRZ3p58ycAZ6YqvN60nwDZY3L6w priority: 102 providerName: ProQuest |
Title | The effect of dapagliflozin ointment on induced psoriasis in an experimental model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39044933 https://www.proquest.com/docview/3105515272 https://www.proquest.com/docview/3084029166 https://pubmed.ncbi.nlm.nih.gov/PMC11262602 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT-MwEB3xIaG9IL52t1AqI3ENjezEbY5QgRBSEUIg9VbZsc0GtU61hQu_nmenRQVuXGMnimZePG_i5xmiU1O6wmmTJqnpmfDrJksUFzqxiNUKMVZrEw4KD2_l9WN2M8pHaySXZ2GiaL_U1ZmfTM989S9qK2fTsrvUiXXvhoNw7AU8nHfXaR0IXcnR4_oLTiBjCzVkL6EoHx811RpDKOfd5-kkCT3DkzSWNP3OK7_KI1fizdUObS-IIjtvXmiX1qzfo63hYit8n-7hYNaoMVjtmEHQe5pUblK_VZ7VlY_qcVZ7hqQb7jNsNq8Btnk1xxWmPFut7c9iQ5wDery6fBhcJ4sGCckMeRFPkMuIwtiU28y5fqllmYE_uFIiqjsFKzh4QIFx6BLfnS5s3gMbyI3NjQBxKMVv2vC1t3-J9YQ0KudW4jFZoVOVKtvHRKmxmAttW9ReGmq8QPl8LEJ3zdAXl7fo5GMY-AybDsrb-hVzYOWUg4TKFv1p7DqeNYU0xqJIs6wQokX9Txb_mBBqX38eASRiDewlBA5_fusR_QIOskZQ1qaNl_-v9hgM40V3AKtRr0ObF5e3d_edCK93aMzWDw |
link.rule.ids | 230,315,730,783,787,888,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,74073,74630 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_8APVF_LZ-RvA1WJK2W59EZTJ1GzIU9laSJtHKTKfdXvzrvbR1OgVf21DauzT3u8vl9wM4VamJjVQ-9VVDudJNQAXjkmqM1QJjrJTKHRTu9qL2Y3A7CAd1wa2o2yq_1sRyoVZ56mrkZ9wpOToNVnY-eqNONcrtrtYSGvOw6KiqMPlavGz17vvTKosDLFEpp4aZjCPoY4OKudGFdXb28jqkTj-c-iW96V-M-btV8kfsuV6D1Ro0kovKy-swp-0GLHXrbfFN6KOzSdWZQXJDFAbAp2FmhvlHZkme2bKTnOSWYAKOrlRkVOCniSIr8AoRlvzk-SelOM4WPF63Hq7atBZLoCPMkRjFvIbHSvtMB8Y0UxmlAWIJk0YY4Y1AKxj0hkD0IVP8B2WswwYig1DpUHEEESnfhgWbW70LpMEjJUKmI3xMEEtf-EI3cWAkcWHnUntw8GWopJ7xRfLtHw9OprdxrroNCGF1PsExaGWfISCNPNip7JqMKlKNhMd-EMSce9Ccsfh0gOPBnr1js-eSD9udgsK0jO39_17HsNx-6HaSzk3vbh9W0O9B1Ux2AAvj94k-RHQxlkf1FPoEpPnQQQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED6xIiFeEAPGCgw8iVerlp24zRMaPyo2RoUQSH2L7NiGoM4pBF7463dO3EKHtNfEipK7i-87-_N9AIemcJnThlFm-iYs3SRUcaGpxVytMMdqbcJB4cuRPL9Nfo3TceQ_1ZFWOZsTm4naVEVYI--JoOQYNFh5z0VaxNXp8Gj6SIOCVNhpjXIan2C5n0jBOrB8fDa6up6vuATwIhtpNaxqQrM-Pm67OIYUz3sPfyY0aIlT1rQ6_Yg3_6VNvstDw3VYiwCS_Gg9_hmWrN-Alcu4Rb4J1-h40rI0SOWIwWR4NyndpHotPalK37DKSeUJFuPoVkOmNX6aqssarxDlyfue_6QRytmC2-HZzck5jcIJdIr1EqdY44jMWMZt4tyg0LJAg6SukJjtnUIrOPSMQiSiC_wfdWbTPqKE1NjUCAQUhfgCHV95-xVIX0ijUm4lPibJNFNM2QEOlBoneaFtF_Zmhspj9Nf5m6-68H1-G-M2bEYob6sXHINWZhzBqezCdmvXfNo22MhFxpIkE6ILgwWLzweEntiLd3x53_TGDieisETjO_9_rwNYwejJf_8cXezCKro9aXlle9B5fnqx3xBoPOv9GEF_AR9j1G8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+dapagliflozin+ointment+on+induced+psoriasis+in+an+experimental+model&rft.jtitle=Journal+of+medicine+and+life&rft.au=Al+bahadly%2C+Waleed+Khaled+Younis&rft.au=Bdioui%2C+Ahlem&rft.au=Al-Gazally%2C+Moaed&rft.au=Al-Saedi%2C+Haider&rft.date=2024-03-01&rft.pub=Carol+Davila+University+Press&rft.issn=1844-122X&rft.eissn=1844-3117&rft.volume=17&rft.issue=3&rft.spage=281&rft.epage=285&rft_id=info:doi/10.25122%2Fjml-2023-0084&rft.externalDBID=PMC11262602 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1844-122X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1844-122X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1844-122X&client=summon |